Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of inactivated and viral vector COVID-19 vaccines in previously infected Thai adults
TCTR20210520004Completed
- Sponsor
- National Research Council of Thailand
- Start
- May 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by National Research Council of Thailand. Primary endpoints: Safety and Immunogenicity. Started May 2021; status: completed.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210520004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210520004.